Some Clinics Will Tell You What They Do.
I'd Rather Show You.
Before I accept a patient, we screen extensively — because I only take on people I am confident our protocol can help. When the evaluation tells me it is a good fit, this is what the follow-up looks like.
Below are examples of real patients from the past five years, in their own words. Every follow-up form is filled out exclusively by the patient, in their own handwriting — in our office, before they ever see me. I do not write them, and I do not edit them.
In some, you will notice two to two-and-a-half years between forms. That gap is deliberate. It is not how long relief took to begin — it is there so you can see that the relief can be maintained over time. Once a patient has completed about a year and a half to two years on the protocol, there is usually no reason to keep coming back. By then they know how to maintain their progress at home, on their own.
*Individual clinical outcomes and timelines vary by patient. Past performance does not guarantee future results.
Patient Example: Gerry, Age 54 — Documented 58% Symptom Improvement Within Initial 2-Week Tracking Period*
Baseline tracking completed on February 24, 2023, showing a severe discomfort score of 31/40. By March 8, 2023, his independent progress form documented a score reduction down to 13/40. This initial data demonstrates how responsively a patient's nerve tissue can begin to stabilize when strictly adhering to the daily home-care stimulation protocol.
Patient Example: Jeanette, Age 82 — Documented Proof That It Is Never Too Late for Nerve Recovery*
Jeanette’s baseline tracking form showed a severe discomfort score of 11/40. By the end of her active protocol, her independent progress form documented a score reduction down to just 2/40.
Her objective data provides powerful proof that you are never too old for nerve tissue to successfully respond to targeted home-care stimulation. At 82 years young, Jeanette’s results demonstrate that significant, long-term symptom management and lasting daily comfort are achievable at any stage of life when the proper clinical protocol is strictly followed.
Patient Example: Joanne — Documented 85% Symptom Reduction with Significant Tracked Progress* Baseline evaluation completed on February 27, 2023, while taking 1,500 mg of Gabapentin daily. Her follow-up evaluation on May 22, 2023, documents a successful, gradual reduction of her daily prescription medication, which was managed directly under clinical supervision.
-
The Maximum Tracked Progress Milestone: On her final tracking form, Joanne's reported scores reached zero across her primary symptom categories, demonstrating a maximum tracked reduction of her daily neuropathy symptoms on her clinical forms.
-
Specialist Release: Following her objective improvement, Joanne continued tracking with her independent specialist until she was officially released from active care. As of June 2024, she has successfully maintained her stability without requiring further specialist intervention.
-
Real-World Impact: Joanne's remarkable progress illustrates how targeting the underlying functional causes of nerve discomfort can allow a patient to experience significant symptom relief. (Note: Any modifications to prescription workloads or dosages must be evaluated and managed strictly by the patient's prescribing physician.)
Patient Example: John, Age 69 — 70% Sustained Symptom Reduction Tracked Over 2 Years*
John’s historical data highlights the clinical value of our long-term home maintenance phase. His records show that by consistently following the independent home protocol after his initial clinical care cycle, stabilized symptom relief can be successfully maintained over multiple years.
Patient Example: Kathleen — Documented 88% Long-Term Symptom Reduction Maintained at Home*
Kathleen achieved her targeted 88% symptom reduction within her first 6 months of active clinical care (by September 2021). Because she achieved a stable clinical response and lived an hour's drive from our office, she transitioned entirely to the independent home maintenance phase. Her 2023 follow-up evaluation documents that she successfully maintained her full 88% improvement completely on her own at home for over 18 months without requiring regular office visits.
Patient Example: Geri — Tracked 83.4% Symptom Improvement Maintained Through Our Long-Term Protocol*
Geri's long-term tracking metrics welfare the sustained impact of a completed active home-care cycle. Her data confirms that following the structured home stabilization phase allows patients to lock in their progress, protecting their tracked 83.4% symptom reduction well into their independent maintenance years.
Patient Example: Beth, Age 72 — Documented Reduction in Burning Sensations From 5/5 to a 0/5 Tracked Clinical Milestone*
Beth's baseline evaluation documented severe, daily burning sensations rated at a maximum 5/5. By following her structured home-care stimulation protocol, her independently completed progress forms documented a steady decrease, ultimately reaching a tracked clinical milestone of 0/5 on her office check-in forms.
This stabilized comfort supported her return to an exceptionally active lifestyle, allowing her to successfully fulfill her personal goal of hiking the Grand Canyon in July 2025.
Patient Example: Kathleen — Documented 97% Symptom Reduction Within 7 Months of Active Home Care*
This individual case study highlights how responsively a patient's nerve tissue can adapt to targeted stimulation during the initial active home-care phase. By combining daily in-home treatments with structured clinical tracking milestones, Kathleen achieved an exceptional 97% reduction in her reported symptom scores over a 7-month duration.
Patient Example: Owen — Objective Progress Monitored via Clinical Intake Tracking*
Owen's side-by-side clinical tracking forms demonstrate the mathematical clarity of our protocol. By evaluating specific symptom categories independently during periodic office check-ins, patients provide clear, documented milestones that guide their customized home-care adjustments.
Patient Example: Gil — Objective Tracking Documents Progress Over Time*
Gil’s side-by-side evaluation forms provide a clear, mathematical look at how nerve tissue can respond over a multi-month period. His initial intake form from November 17, 2025, documents severe discomfort across multiple categories.
By his follow-up check-in on January 12, 2026, his independently completed progress form shows an exceptional shift, with his reported scores dropping to zero across his primary symptom tracking categories. This objective data highlights the real-world impact of a strictly followed home-care protocol, allowing patients to document their own milestones as their daily comfort stabilizes.
